European Case Law Identifier: | ECLI:EP:BA:1992:T026889.19920206 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 06 February 1992 | ||||||||
Case number: | T 0268/89 | ||||||||
Application number: | 82100942.0 | ||||||||
IPC class: | A61F 13/02 A61N 1/42 |
||||||||
Language of proceedings: | DE | ||||||||
Distribution: | |||||||||
Download and more information: |
|
||||||||
Title of application: | - | ||||||||
Applicant name: | Latzke | ||||||||
Opponent name: | Pharma Stroschein | ||||||||
Board: | 3.2.02 | ||||||||
Headnote: | Where the inefficacy of a device or process forming part of the prior art is only recognised or alleged after the date of priority or filing, this cannot be cited in formulating the problem. This particularly applies where a problem of the "problem invention" type (cf. T 2/83, "Simethicone Tablet"/RIDER, OJ EPO 1984, 265) is used as an argument to show that an inventive step has taken place. The guiding consideration in assessing inventive step is the knowledge of the skilled person before the date of priority or filing (cf. point 5, paragraph 3, of the Reasons). | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Formulation of the problem where the inefficacy of a known device is only recognised after the date of filing Inventive step (yes, after amendment of claims) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t890268ep1.html
Date retrieved: 17 May 2021
4 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.Offical Journal of the EPO
XOJ EPO SE 1/2021, p179 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2020)
XOJ EPO SE 1/2020, p174 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2019)
XOJ EPO SE 1/2019, p158 - XVI. - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2018)